These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
960 related articles for article (PubMed ID: 18483078)
1. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078 [TBL] [Abstract][Full Text] [Related]
3. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Dambacher J; Beigel F; Seiderer J; Haller D; Göke B; Auernhammer CJ; Brand S Gut; 2007 Sep; 56(9):1257-65. PubMed ID: 17449633 [TBL] [Abstract][Full Text] [Related]
4. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells. Crome SQ; Wang AY; Kang CY; Levings MK Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310 [TBL] [Abstract][Full Text] [Related]
5. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136 [TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of decoy receptor 3 in Crohn's disease. Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087 [TBL] [Abstract][Full Text] [Related]
7. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction. Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554 [TBL] [Abstract][Full Text] [Related]
10. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Veny M; Esteller M; Ricart E; Piqué JM; Panés J; Salas A Aliment Pharmacol Ther; 2010 Mar; 31(5):561-72. PubMed ID: 19958311 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype. Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Shkoda A; Ruiz PA; Daniel H; Kim SC; Rogler G; Sartor RB; Haller D Gastroenterology; 2007 Jan; 132(1):190-207. PubMed ID: 17241871 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427 [TBL] [Abstract][Full Text] [Related]
14. The Th17/Treg imbalance in patients with acute coronary syndrome. Cheng X; Yu X; Ding YJ; Fu QQ; Xie JJ; Tang TT; Yao R; Chen Y; Liao YH Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918 [TBL] [Abstract][Full Text] [Related]
15. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Nagalakshmi ML; Rascle A; Zurawski S; Menon S; de Waal Malefyt R Int Immunopharmacol; 2004 May; 4(5):679-91. PubMed ID: 15120652 [TBL] [Abstract][Full Text] [Related]
18. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. Pizarro TT; Michie MH; Bentz M; Woraratanadharm J; Smith MF; Foley E; Moskaluk CA; Bickston SJ; Cominelli F J Immunol; 1999 Jun; 162(11):6829-35. PubMed ID: 10352304 [TBL] [Abstract][Full Text] [Related]
19. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. Olivito B; Simonini G; Ciullini S; Moriondo M; Betti L; Gambineri E; Cantarini L; De Martino M; Azzari C; Cimaz R J Rheumatol; 2009 Sep; 36(9):2017-24. PubMed ID: 19648312 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]